MDAI vs CBLL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

MDAI

46.5
AI Score
VS
MDAI Wins

CBLL

38.4
AI Score

Investment Advisor Scores

MDAI

47score
Recommendation
HOLD

CBLL

38score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MDAI CBLL Winner
Forward P/E 52.356 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -40.5% 32.5% CBLL
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 46.5/100 38.4/100 MDAI
Profit Margin -82.0% -64.7% CBLL
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MDAI

Relative Price Performance (Last 90 Days)

MDAI 1M: -1.2% · 3M: -39.6% CBLL 1M: +40.9% · 3M: +27.0%

Current Technical Phase

MDAI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.0 · Price: $1.62

CBLL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.5% over 20 days), RSI 70

RSI (14): 70.0 · Price: $23.83

Fundamentals Snapshot

Metric MDAI CBLL
Market Cap
Forward P/E -4.5 -15.7
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% 0.3%
Gross Margin 0.4% 0.9%
Operating Margin -1.2% -0.7%
EPS -0.31 -1.72
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDAI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.